About this episode
With the rollout of two new malaria vaccines on the horizon in Africa, the outlook for fighting the disease looks optimistic. But is it enough?
In this episode of our Africa Science Focus Science Explained series, Michael Charles, head of the RBM Partnership to End Malaria, tells us why he believes Africa must lead the drive to end the disease. Charles hails the “groundbreaking” latest WHO-recommended malaria vaccine, R21/Matrix M, but stresses the need to keep up other malaria control measures too.
We also hear from Chika Offor, CEO of the Vaccine Network for Disease Control, who says people in the region must see the value of the vaccine if the rollout campaign is to be successful.
----------------------------------------
This piece was produced by SciDev.Net’s Sub-Saharan Africa English desk.
Do you have any comments, questions or feedback about our podcast episodes? Let us know at [email protected]
Get every episode summarized
Each time Africa Science Focus publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Africa Science Focus
Climate-smart actions to reduce crop loss in Africa
Africa Science Focus
How can better data curb Africa’s crop loss crisis?
Africa Science Focus
Why plant health matters for One Health systems
Africa Science Focus
Advancing gender equality in research
Africa Science Focus